查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2032252

全球心臟假體市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Cardiac Prosthetic Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球心臟假體市場預計將從2025年的98.8億美元成長至2034年的212.1億美元，2026年至2034年的複合年成長率（CAGR）為8.86%。心血管疾病盛行率的上升和人口老化是推動該市場顯著成長的主要因素。心臟瓣膜、心律調節器和心室輔助醫療設備等心臟假體對於治療複雜心臟疾病和提高患者存活率至關重要。醫療和外科技術的進步提高了這些裝置的安全性和有效性，促進了其更廣泛的應用。此外，診斷能力的提升使得心臟疾病的早期發現成為可能，進一步推動了市場擴張。

成長要素包括醫療保健支出不斷增加、心臟健康意識日益增強以及醫療器材設計持續創新。微創手術和經導管技術的廣泛應用縮短了患者的復原時間，並改善了治療效果。醫療基礎設施的擴建，尤其是在新興國家，也促進了市場成長。此外，醫療設備製造商與研究機構之間的合作正在加速下一代心臟假體解決醫療設備的研發。

由於生物材料技術的持續進步以及與數位醫療的融合，心臟假體市場的未來前景仍然光明。能夠進行即時監測的智慧連網設備的開發有望徹底改變心臟醫療保健產業。隨著先進療法的普及，新興市場有望提供巨大的成長機會。隨著全球心臟病負擔的持續加重，心臟假體市場預計將保持永續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 擴散與成長前景圖
  • 價值鏈分析
  • 法律規範
    • 符合標準
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心臟人工器官市場：依產品分類

  • 市場分析、洞察與預測
  • 心臟節律器（植入式心臟節律器、體外心臟節律器）
  • 心臟瓣膜（機械瓣膜、生物瓣膜、經導管心臟瓣膜）

第5章：全球心臟人工器官市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第6章 全球心臟人工器官市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈通路夥伴（視情況而定）
  • 市場佔有率定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Abiomed
    • AtriCure
    • Biotronik
    • Boston Scientific Corporation
    • CryoLife
    • Edwards Lifesciences Corporation
    • Labcor Laboratorios
    • Lepu Medical Technology
    • Lifetech Scientific
    • LivaNova
    • Medtronic
    • Meril Life Sciences
    • MicroPort Scientific
    • Siemens Healthineers
簡介目錄
Product Code: VMR112112057

The global cardiac prosthetic devices market size is expected to reach USD 21.21 Billion in 2034 from USD 9.88 Billion in 2025, growing at a CAGR of 8.86 during 2026-2034.This market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and the increasing aging population worldwide. Cardiac prosthetic devices, including heart valves, pacemakers, and ventricular assist devices, are essential for managing complex heart conditions and improving patient survival rates. Advancements in medical technology and surgical techniques have enhanced the safety and effectiveness of these devices, encouraging wider adoption. Additionally, improved diagnostic capabilities are enabling early detection of heart disorders, further supporting market expansion.

Key drivers include increasing healthcare expenditure, growing awareness about cardiac health, and continuous innovation in device design. Minimally invasive procedures and transcatheter technologies have gained popularity, reducing recovery time and improving patient outcomes. The expansion of healthcare infrastructure, particularly in emerging economies, is also contributing to the market's growth. Furthermore, collaborations between medical device companies and research institutions are accelerating the development of next-generation cardiac prosthetic solutions.

Future prospects for this market remain promising, with ongoing advancements in biomaterials and digital health integration. The development of smart and connected devices capable of real-time monitoring is expected to transform cardiac care. Emerging markets are likely to provide significant growth opportunities due to increasing access to advanced treatments. As the global burden of heart disease continues to rise, the cardiac prosthetic devices market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Pacemaker (Implantable Pacemaker, External Pacemakers)
  • Heart Valves (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve)

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

COMPANIES PROFILED

  • Abbott Laboratories, Abiomed, AtriCure, Biotronik, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Labcor Laboratorios, Lepu Medical Technology, Lifetech Scientific, LivaNova, Medtronic, Meril Life Sciences, MicroPort Scientific, Siemens Healthineers

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation Data Visualization
    • 1.3.3 Data Validation Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Pacemaker (Implantable Pacemaker, External Pacemakers) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Heart Valves (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain Channel Partners (based on availability)
  • 7.4. Market Share Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CARDIAC PROSTHETIC DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Abbott Laboratories
    • 8.2.2 Abiomed
    • 8.2.3 AtriCure
    • 8.2.4 Biotronik
    • 8.2.5 Boston Scientific Corporation
    • 8.2.6 CryoLife
    • 8.2.7 Edwards Lifesciences Corporation
    • 8.2.8 Labcor Laboratorios
    • 8.2.9 Lepu Medical Technology
    • 8.2.10 Lifetech Scientific
    • 8.2.11 LivaNova
    • 8.2.12 Medtronic
    • 8.2.13 Meril Life Sciences
    • 8.2.14 MicroPort Scientific
    • 8.2.15 Siemens Healthineers